6-Substituted Sulfocoumarins Are Selective Carbonic Anhdydrase IX and XII Inhibitors with Significant Cytotoxicity against Colorectal Cancer Cells
摘要:
6-Substituted sulfocoumarins bearing the carboxamido, trimethylammonium as well as the cyano and methoxy moieties with interesting inhibitory activity/selectivity against the tumor associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA IX and XII are reported. Moieties leading to the best inhibition were tert-butylcarboxamido, phenylcarboxamido, and 4-pyridylcarboxamido, with K-I values of 2.1-8.1 nM. No inhibition of the off-target hCA II and I was observed. A number of these compounds were evaluated against HT-29 colon cancer cell lines ex vivo. Compounds 9c and 9e revealed effective cytotoxic effects after 72 h of incubation in both normoxic and hypoxic conditions, unlike sulfonamide CA inhibitors that show such effects only in hypoxia. These results may be of particular importance for the choice of future drug candidates targeting hypoxic tumors and metastases, considering the fact that a sulfonamide CA IX inhibitor (SLC-0111) is presently in phase I clinical trials.
Ureidosulfocoumarin Derivatives As Selective and Potent Carbonic Anhydrase IX and XII Inhibitors
作者:Priti Singh、Dilep Kumar Sigalapalli、Nerella Sridhar Goud、Baijayantimala Swain、Santosh Kumar Sahoo、Andrea Angeli、Afzal B. Shaik、Venkata Madhavi Yaddanapudi、Claudiu T. Supuran、Mohammed Arifuddin
DOI:10.1002/cmdc.202100725
日期:2022.3.4
the focus of increased attention. Herein we report 30 non-sulfonamide sulfocoumarin derivatives. All compounds showed selectivity for the tumor-associated isoenzymes hCA IX and XII over the cytosolic isoenzymes hCA I and II. These results provide a new perspective for the development of non-sulfonamide derivatives as selective CA inhibitors.
鉴于磺胺类碳酸酐酶 (CA) 抑制剂的各种缺点,非磺胺类 CA 抑制剂是越来越受关注的焦点。在这里,我们报告了 30 种非磺酰胺磺基香豆素衍生物。所有化合物都显示出对肿瘤相关同工酶 hCA IX 和 XII 的选择性高于胞质同工酶 hCA I 和 II。这些结果为开发非磺胺类衍生物作为选择性CA抑制剂提供了新的视角。
Glyoxalase 1 and 2 Enzyme Inhibitory Activity of 6-Sulfamoylsaccharin and Sulfocoumarin Derivates
glyoxalase enzymes represent a cellular defence system against the accumulation of cytotoxic α- oxoaldehydes leading to apoptosis. The potential of glyoxalase inhibitors to act as novel anti-cancer agents for drugresistant tumours that over-express glyoxalase is currently under investigation. In the present study, a series of 6- sulfamoylsaccharin and 1,2-benzoxathiine 2,2-dioxide (sulfocoumarin - coumarin
New coumarin/sulfocoumarin linked phenylacrylamides as selective transmembrane carbonic anhydrase inhibitors: Synthesis and in-vitro biological evaluation
作者:Baijayantimala Swain、Andrea Angeli、Priti Singh、Claudiu T. Supuran、Mohammed Arifuddin
DOI:10.1016/j.bmc.2020.115586
日期:2020.8
Two novel series of phenylacrylamide linked coumarins and sulfocoumarins (6a-p, 8a-i, and 14a-g) were synthesized and evaluated against four physiologically relevant human carbonicanhydrases (hCAs, EC 4.2.1.1), isoforms hCA I, hCA II, hCA IX and hCA XII for their inhibitory action. All new compounds when screened for carbonicanhydrase inhibitory activity have shown selective inhibition towards the
Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII
作者:Srinivas Angapelly、P. V. Sri Ramya、Andrea Angeli、Claudiu T. Supuran、Mohammed Arifuddin
DOI:10.1002/cmdc.201700446
日期:2017.10.9
series of sulfocoumarin-, coumarin-, and 4-sulfamoylphenyl-bearing indazole-3-carboxamide hybrids were synthesized and investigated as inhibitors of human carbonicanhydrase (hCA, EC 4.2.1.1) isoforms I, II, IX, and XII. Most of these compounds displayed excellent potency and selectivity against hCA isoforms IX and XII, which have been recently validated as antitumor drug targets.
6-Substituted Sulfocoumarins Are Selective Carbonic Anhdydrase IX and XII Inhibitors with Significant Cytotoxicity against Colorectal Cancer Cells
作者:Aiga Grandane、Muhammet Tanc、Lorenzo Di Cesare Mannelli、Fabrizio Carta、Carla Ghelardini、Raivis Žalubovskis、Claudiu T. Supuran
DOI:10.1021/acs.jmedchem.5b00523
日期:2015.5.14
6-Substituted sulfocoumarins bearing the carboxamido, trimethylammonium as well as the cyano and methoxy moieties with interesting inhibitory activity/selectivity against the tumor associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA IX and XII are reported. Moieties leading to the best inhibition were tert-butylcarboxamido, phenylcarboxamido, and 4-pyridylcarboxamido, with K-I values of 2.1-8.1 nM. No inhibition of the off-target hCA II and I was observed. A number of these compounds were evaluated against HT-29 colon cancer cell lines ex vivo. Compounds 9c and 9e revealed effective cytotoxic effects after 72 h of incubation in both normoxic and hypoxic conditions, unlike sulfonamide CA inhibitors that show such effects only in hypoxia. These results may be of particular importance for the choice of future drug candidates targeting hypoxic tumors and metastases, considering the fact that a sulfonamide CA IX inhibitor (SLC-0111) is presently in phase I clinical trials.